On the other hand, US FDA firstly approved Sevelamer HCl (Renagel®) on Oct 30, 1998. Renvela® is a non-absorbed phosphate binding crosslinked polymer, containing multiple amines separated by one carbon from the polymer backbone. These amines exist in a protonated form in the intestine and...